At a glance
ClinicalIndex Comparison RecordN/ACompleted· 400 enrolled
Drug / intervention
Lung ultrasoundother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Prognostic Value of Lung Ultrasound in ST Segment Elevation Acute Myocardial Infarction (LUS-AMI)
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau·observational·Posted Aug 26, 2020·Updated Mar 1, 2023
In Brief
An observational study evaluating Lung ultrasound for Acute Myocardial Infarction and Heart Failure. Completed, enrolled 400 participants across 2 sites.
Detailed Summary
The purpose of this study is to asses the prognostic value of lung ultrasound in patients with ST-segment elevation acute myocardial infarction.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAcute Myocardial Infarction, Heart Failure
CountriesSpain
Timeline
N/ACompletedFinished
202120222023202420252026
Enrollment StartJun 2020
First PostedAug 2020
Primary CompletionDec 2022
TodayJul 2026
First PostedAug 26, 2020
Enrollment StartJun 15, 2020
Primary CompletionDec 31, 2022
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 5.9 years ago
Interventions
Lung ultrasoundother
Lung ultrasound performed with a portable device with an 8 zones protocol within the first 24 hours after and ST-segment elevation acute myocardial infarction